The Japanese Government’s Bioeconomy Strategy advances biotechnology developments and provides U.S. companies with potential export opportunities.

Saudi Arabia’s largest centralized healthcare tender and procurement law guides public procurement.

The Kenyan government is investing heavily in cancer care facilities.

Japan is taking measures to promote the development and commercialization of software as a medical device (SaMD).

Japan is an attractive market for U.S. dietary supplements makers, but exporters must effectively navigate the country’s complex health claim labeling system.

Uruguay’s roadmap for digital development will create opportunities for software and hardware providers, telecom and network services companies.

Spain faces the ongoing challenge of reducing the weight of the healthcare sector within the national budget, in particular the pharmaceutical component.

New funding for Hungary’s Healthcare Network offers opportunities for U.S. healthcare and MedTech companies.

China’s market for hospitals and senior center construction is large and growing, but government limits on procurement pose a challenge for U.S. firms.

The Singapore Ministry of Health Standards Drug List, highlights the addition of sixteen antiretroviral drugs. 

Tanzania is a country with many patients presenting HPV related cancers. 

China eases regulations on over the counter (OTC) medicine as consumer demands for self-medication and preventative care drugs provide market opportunities.

The healthcare market in China and Hong Kong is experiencing significant growth. 

The Saudi Arabia  2030 Vision for Healthcare Embraces Public-Private Partnerships. 

Positive regulatory changes in Algeria’s pharmaceutical industry support American companies interested in the country’s pharmaceutical sector.